Deep Learning-based Auto-segmentation of Clinical Target Volumes for Radiotherapy Treatment of Cervical Cancer
Overview
General Medicine
Authors
Affiliations
Objectives: Because radiotherapy is indispensible for treating cervical cancer, it is critical to accurately and efficiently delineate the radiation targets. We evaluated a deep learning (DL)-based auto-segmentation algorithm for automatic contouring of clinical target volumes (CTVs) in cervical cancers.
Methods: Computed tomography (CT) datasets from 535 cervical cancers treated with definitive or postoperative radiotherapy were collected. A DL tool based on VB-Net was developed to delineate CTVs of the pelvic lymph drainage area (dCTV1) and parametrial area (dCTV2) in the definitive radiotherapy group. The training/validation/test number is 157/20/23. CTV of the pelvic lymph drainage area (pCTV1) was delineated in the postoperative radiotherapy group. The training/validation/test number is 272/30/33. Dice similarity coefficient (DSC), mean surface distance (MSD), and Hausdorff distance (HD) were used to evaluate the contouring accuracy. Contouring times were recorded for efficiency comparison.
Results: The mean DSC, MSD, and HD values for our DL-based tool were 0.88/1.32 mm/21.60 mm for dCTV1, 0.70/2.42 mm/22.44 mm for dCTV2, and 0.86/1.15 mm/20.78 mm for pCTV1. Only minor modifications were needed for 63.5% of auto-segmentations to meet the clinical requirements. The contouring accuracy of the DL-based tool was comparable to that of senior radiation oncologists and was superior to that of junior/intermediate radiation oncologists. Additionally, DL assistance improved the performance of junior radiation oncologists for dCTV2 and pCTV1 contouring (mean DSC increases: 0.20 for dCTV2, 0.03 for pCTV1; mean contouring time decrease: 9.8 min for dCTV2, 28.9 min for pCTV1).
Conclusions: DL-based auto-segmentation improves CTV contouring accuracy, reduces contouring time, and improves clinical efficiency for treating cervical cancer.
Bolten J, Neugebauer D, Grott C, Weykamp F, Ristau J, Mende S Clin Transl Radiat Oncol. 2025; 52:100933.
PMID: 40028424 PMC: 11871478. DOI: 10.1016/j.ctro.2025.100933.
Jiang H, Qin S, Jia L, Wei Z, Xiong W, Xu W J Appl Clin Med Phys. 2024; 25(12):e14560.
PMID: 39540681 PMC: 11633815. DOI: 10.1002/acm2.14560.
Peng H, Liu T, Li P, Yang F, Luo X, Sun X Sci Rep. 2024; 14(1):26937.
PMID: 39505991 PMC: 11542092. DOI: 10.1038/s41598-024-78424-0.
Ma C, Zhou J Cureus. 2024; 16(9):e69703.
PMID: 39429366 PMC: 11490271. DOI: 10.7759/cureus.69703.
Wu Z, Wang D, Xu C, Peng S, Deng L, Liu M J Appl Clin Med Phys. 2024; 26(1):e14553.
PMID: 39401180 PMC: 11712972. DOI: 10.1002/acm2.14553.